Plain-English translation of NCT07657546 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing a new imaging technology called magnetocardiography to better detect when the heart isn't getting enough blood flow in patients who have chest pain but normal or near-normal coronary arteries on standard tests. The study aims to see if this scan can identify a common heart condition that is sometimes missed by regular testing methods.
Many people experience chest pain and have normal coronary angiograms or CT scans, but still suffer from inadequate blood flow to their heart muscle. This trial exists to determine if the new scanning technology can better identify this hidden condition so doctors can treat patients more effectively.
You likely qualify if…
You likely don't qualify if…
As a participant, you would undergo the new magnetocardiography scan, which is a non-invasive imaging test that measures the magnetic fields produced by your heart's electrical activity. You may also be asked to complete additional heart function tests as part of the study evaluation. The study involves visits to complete these tests, though the exact number and timing of visits would be explained to you when you enroll.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
China
Sponsor
Qilu Hospital of Shandong University
Enrollment target
~3,786 participants
Started
April 2025
Primary completion
June 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jiaojiao Pang, Doctor
Qliu Hospital of Shandong University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.